TV News LIES

The Food and Drug Administration vowed Thursday to reverse the approval of a patch for injured knees that it granted in 2008 after being pressured by four New Jersey congressmen and its own commissioner.

The patch, known as Menaflex and manufactured by ReGen Biologics Inc., works in a fundamentally different way than devices that ReGen had claimed were similar enough that Menaflex did not need to be tested thoroughly, the F.D.A. decided. Its approval was an “error,” the agency said in a press release.

US officials have charged 73 people over what is thought to be the largest ever attempt to defraud the country's medical insurance system. Prosecutors say a network of Armenian gangsters and their associates set up fake clinics using stolen identities to make false claims for treatment.

Investigators said more than $35m (£22m) was paid out. A US Attorney said the scheme's scope and sophistication put the traditional mafia to shame.

Want to know the disturbing truth about the greed-driven cancer industry? I've written about it using blunt language here on NaturalNews, and awareness is spreading. People are sick of pinkwashing nonsense, and they're wising up to the fundraising "run for the cure" scams that only funnel more money into corrupt, Pharma-dominated cancer non-profits.

Now a new study published in the Journal of the American Medical Association sheds new light on just how cruel and greedy the cancer industry really is. It turns out that even when cancer patients are terminal -- meaning they're expected to die soon -- the cancer industry herds them into yet more screening, mammograms, biopsies and lab tests in order to generate more profits from Medicare before the patient expires.

Osteoporosis drugs used by millions of women to prevent bones from breaking may increase the chances for an unusual type of thigh fracture, U.S. health officials warned on Wednesday. The drugs known as bisphosphonates include Merck & Co Inc's Fosamax, Roche Holding AG's Boniva, Novartis AG's Reclast and Warner Chilcott Plc's Actonel.

The action could drive patients to Amgen Inc's just-launched rival medicine, Prolia, a different type of osteoporosis drug that is the company's most important future growth driver.

Agribusiness lobbyists took an active role in writing a U.K. government report on genetically modified (GM) foods, two former members of the Food Standards Agency's (FSA's) steering group have revealed.

Dr. Helen Wallace of Genewatch U.K. and Professor Brian Wynne both resigned recently in protest of what Wynne calls a "dogmatically entrenched" pro-GM attitude at the FSA, whose head recently accused GM critics of being "anti-science."

The first person treated with embryonic stem cells is an Atlanta patient paralyzed by a recent spine injury. The Geron Corp. GRNOPC1 stem cells come from embryos left over after in vitro fertilization and donated by the parents. The FDA approved the study in early 2009.

The clinical trial is a first step toward an eventual cure for paralysis, says study leader Richard Fessler, MD, PhD, professor of neurological surgery at Northwestern University Feinberg School of Medicine and a surgeon at Northwestern Memorial Hospital.